Skip to main content
. 2022 Sep 12;81(6):770–785. doi: 10.1111/his.14780

Figure 2.

Figure 2

A, Schematic illustration of different scenarios of human epidermal growth factor receptor 2 (HER2) expression in breast cancer and the corresponding score from different existing guidelines. B, Recommended HER2 scoring algorithm based on immunohistochemistry (IHC)‐stained slides.